These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8024189)

  • 1. Virus-directed enzyme/prodrug therapy (VDEPT). Selectively engineering drug sensitivity into tumors.
    Huber BE; Richards CA; Austin EA
    Ann N Y Acad Sci; 1994 May; 716():104-14; discussion 140-3. PubMed ID: 8024189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line.
    Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE
    Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.
    Huber BE; Austin EA; Good SS; Knick VC; Tibbels S; Richards CA
    Cancer Res; 1993 Oct; 53(19):4619-26. PubMed ID: 8402637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter.
    Cao G; Kuriyama S; Gao J; Kikukawa M; Cui L; Nakatani T; Zhang X; Tsujinoue H; Pan X; Fukui H; Qi Z
    Gene Ther; 1999 Jan; 6(1):83-90. PubMed ID: 10341879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional delivery and selective expression of a high-activity yeast cytosine deaminase in an intrahepatic colon cancer model.
    Zhang M; Li S; Nyati MK; DeRemer S; Parsels J; Rehemtulla A; Ensminger WD; Lawrence TS
    Cancer Res; 2003 Feb; 63(3):658-63. PubMed ID: 12566311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the human carcinoembryonic antigen promoter core region in colorectal carcinoma-selective cytosine deaminase gene therapy.
    Cao G; Kuriyama S; Cui L; Nagao S; Pan X; Toyokawa Y; Zhang X; Nishiwaki I; Qi Z
    Cancer Gene Ther; 1999; 6(6):572-80. PubMed ID: 10608354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of carcinoembryonic antigen-specific prodrug gene therapy for experimental colon cancer.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Ojima T; Yamaue H
    Surgery; 2003 Mar; 133(3):309-17. PubMed ID: 12660644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
    Topf N; Worgall S; Hackett NR; Crystal RG
    Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy.
    Richards CA; Austin EA; Huber BE
    Hum Gene Ther; 1995 Jul; 6(7):881-93. PubMed ID: 7578407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic administration of a recombinant vaccinia virus expressing the cytosine deaminase gene and subsequent treatment with 5-fluorocytosine leads to tumor-specific gene expression and prolongation of survival in mice.
    Gnant MF; Puhlmann M; Alexander HR; Bartlett DL
    Cancer Res; 1999 Jul; 59(14):3396-403. PubMed ID: 10416601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene.
    Shen LZ; Wu WX; Xu DH; Zheng ZC; Liu XY; Ding Q; Hua YB; Yao K
    World J Gastroenterol; 2002 Apr; 8(2):270-5. PubMed ID: 11925606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene.
    Khil MS; Kim JH; Mullen CA; Kim SH; Freytag SO
    Clin Cancer Res; 1996 Jan; 2(1):53-7. PubMed ID: 9816090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer.
    Nyati MK; Sreekumar A; Li S; Zhang M; Rynkiewicz SD; Chinnaiyan AM; Rehemtulla A; Lawrence TS
    Cancer Res; 2002 Apr; 62(8):2337-42. PubMed ID: 11956093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo gene transfer of a suicide gene under the transcriptional control of the carcinoembryonic antigen promoter results in bone marrow transduction but can avoid bone marrow suppression.
    Cao G; Kuriyama S; Gao J; Mitoro A; Cui L; Nagao S; Zhang X; Tsujinoue H; Pan X; Fukui H; Qi Z
    Int J Oncol; 1999 Jul; 15(1):107-12. PubMed ID: 10375601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
    Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study on human pancreatic carcinoma treated by cytosine deaminase gene therapy].
    Zhang S; Yuan S
    Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):249-51. PubMed ID: 11798763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model.
    Nyati MK; Symon Z; Kievit E; Dornfeld KJ; Rynkiewicz SD; Ross BD; Rehemtulla A; Lawrence TS
    Gene Ther; 2002 Jul; 9(13):844-9. PubMed ID: 12080378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia.
    Fox ME; Lemmon MJ; Mauchline ML; Davis TO; Giaccia AJ; Minton NP; Brown JM
    Gene Ther; 1996 Feb; 3(2):173-8. PubMed ID: 8867865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
    Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
    J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine.
    Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG
    Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.